Search results for the GEO ID: GSE20070 |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM501704 | GPL570 |
|
negative control siRNA
|
Seg-1 cells
|
cell type: lung adenocarcinoma cell line
cell line: Seg-1
sirna: negative control
|
Seg-1 cells transfected with negative control siRNA for 72hrs
|
Sample_geo_accession | GSM501704
| Sample_status | Public on Jan 28 2010
| Sample_submission_date | Jan 27 2010
| Sample_last_update_date | Jan 27 2010
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | Seg-1 cells were reverse transfected with pre-designed siRNA from Ambion according to Invitrogen’s Lipofectamine™ RNAiMAX Reverse Transfection protocol. Briefly, transfection complexes were formed in 6-well culture plates in OPTI-1 MEM culture media to give final siRNA concentrations of 25-200 nM. A control siRNA, with no homology to any known gene sequence, was included as a negative control. Cell suspensions were added to formed complexes to give a seeding density of 1.0x105 cells per well and incubated at 37°C with 5% C02 for 72 hours. Cells were then harvested for RNA.
| Sample_growth_protocol_ch1 | Adherent human Seg-1 cells (generously provided by David Beer, Ph.D., University of Michigan, Ann Arbor, MI) were cultured in DMEM supplemented with 8% fetal bovine serum at 37°C with 5% CO2. Although originally believed to be an esophageal adenocarcinoma cell line, Seg-1 has recently been confirmed to be the human lung adenocarcinoma cell line H460 (Dr. David Beer, personal communication).
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA was extracted with the Qiagen Rneasy mini RNA extraction kit.
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Total RNA (5 μg) was used for 1st- and 2nd -strand cDNA synthesis with oligo-dT containing T7 promoter from the One-Cycle Target Labeling and Control Reagents kit (Affymetrix Cat. No. 900493). Synthesized double stranded cDNA was used as template to generate Biotin-labeled cRNA which was then fragmented to 35-200 bases in size using fragmentation buffer (Affymetrix Cat. No. 900493).
| Sample_hyb_protocol | 15 μg of Biotin-labeled cRNA in 250 μl hybridization cocktail was injected into each array and hybridized at 45oC for 16 hours with rotation of 60 rpm in an Affymetrix GeneChip Hybridization Oven 640. After hybridization, the staining and washing of each array was performed on Affymetrix GeneChip Fluidics Station 450 using Streptavidin Phycoerythrin, goat IgG, and Biotinylated anti-streptavidin antibody.
| Sample_scan_protocol | Each array was scanned with an Affymetrix GeneChip 7G 2 Plus Scanner.
| Sample_data_processing | Expression values were processed using GeneChip Operating Software (GCOS) v 1.4, MAS5, Baseline level: 100 fluorescence unit.
| Sample_platform_id | GPL570
| Sample_contact_name | Paul ,R,Murphy
| Sample_contact_email | prmurphy@dal.ca
| Sample_contact_phone | 902-494-1579
| Sample_contact_department | Physiology and Biophysics
| Sample_contact_institute | Dalhousie University
| Sample_contact_address | 5850 College Street
| Sample_contact_city | Halifax
| Sample_contact_state | Nova Scotia
| Sample_contact_zip/postal_code | B3H 1X5
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM501nnn/GSM501704/suppl/GSM501704.CEL.gz
| Sample_series_id | GSE20070
| Sample_data_row_count | 54675
| |
|
GSM501705 | GPL570 |
|
FGF-AS siRNA
|
Seg-1 cells
|
cell type: lung adenocarcinoma cell line
cell line: Seg-1
sirna: FGF-AS
|
Seg-1 cells transfected with FGF-AS siRNA for 72hrs
|
Sample_geo_accession | GSM501705
| Sample_status | Public on Jan 28 2010
| Sample_submission_date | Jan 27 2010
| Sample_last_update_date | Jan 27 2010
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | Seg-1 cells were reverse transfected with pre-designed siRNA from Ambion according to Invitrogen’s Lipofectamine™ RNAiMAX Reverse Transfection protocol. Briefly, transfection complexes were formed in 6-well culture plates in OPTI-1 MEM culture media to give final siRNA concentrations of 25-200 nM. A control siRNA, with no homology to any known gene sequence, was included as a negative control. Cell suspensions were added to formed complexes to give a seeding density of 1.0x105 cells per well and incubated at 37°C with 5% C02 for 72 hours. Cells were then harvested for RNA.
| Sample_growth_protocol_ch1 | Adherent human Seg-1 cells (generously provided by David Beer, Ph.D., University of Michigan, Ann Arbor, MI) were cultured in DMEM supplemented with 8% fetal bovine serum at 37°C with 5% CO2. Although originally believed to be an esophageal adenocarcinoma cell line, Seg-1 has recently been confirmed to be the human lung adenocarcinoma cell line H460 (Dr. David Beer, personal communication).
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Total RNA was extracted with the Qiagen Rneasy mini RNA extraction kit.
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Total RNA (5 μg) was used for 1st- and 2nd -strand cDNA synthesis with oligo-dT containing T7 promoter from the One-Cycle Target Labeling and Control Reagents kit (Affymetrix Cat. No. 900493). Synthesized double stranded cDNA was used as template to generate Biotin-labeled cRNA which was then fragmented to 35-200 bases in size using fragmentation buffer (Affymetrix Cat. No. 900493).
| Sample_hyb_protocol | 15 μg of Biotin-labeled cRNA in 250 μl hybridization cocktail was injected into each array and hybridized at 45oC for 16 hours with rotation of 60 rpm in an Affymetrix GeneChip Hybridization Oven 640. After hybridization, the staining and washing of each array was performed on Affymetrix GeneChip Fluidics Station 450 using Streptavidin Phycoerythrin, goat IgG, and Biotinylated anti-streptavidin antibody.
| Sample_scan_protocol | Each array was scanned with an Affymetrix GeneChip 7G 2 Plus Scanner.
| Sample_data_processing | Expression values were processed using GeneChip Operating Software (GCOS) v 1.4, MAS5, Baseline level: 100 fluorescence unit.
| Sample_platform_id | GPL570
| Sample_contact_name | Paul ,R,Murphy
| Sample_contact_email | prmurphy@dal.ca
| Sample_contact_phone | 902-494-1579
| Sample_contact_department | Physiology and Biophysics
| Sample_contact_institute | Dalhousie University
| Sample_contact_address | 5850 College Street
| Sample_contact_city | Halifax
| Sample_contact_state | Nova Scotia
| Sample_contact_zip/postal_code | B3H 1X5
| Sample_contact_country | Canada
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM501nnn/GSM501705/suppl/GSM501705.CEL.gz
| Sample_series_id | GSE20070
| Sample_data_row_count | 54675
| |
|
|
|
Make groups for comparisons |
(2 groups will be compared at a time) |
|
Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|
Select expression type |
Transcripts profile based on; |
A. Differential status (Up/Down regulation) |
|
|
Regulation type |
|
Fold change |
|
p-value |
|
|
|
B. Absolute calls (Transcribed/Not-detected) |
|
|
Derive calls within/across groups |
Within groups |
|
|
Detection status |
|
Percentage detection |
|
|
Across groups |
|
|
Detection status |
First group: |
- |
Second group:
|
Percentage detection |
First group: |
- |
Second group:
|
|
|
|
Filter results by number of probes |
|
|